Use of NOX inhibitors for treatment of cancer
US12011436B2 · kind B2 · utility
0Cited by
23References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 1, 2018 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Nov 4, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to compounds, methods, compositions and uses that are able to restore responsiveness to immunotherapy, in particular immune check point inhibitors or anti-cancer vaccine or to anti-angiogenesis treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.